🔗 Permalink

Inventor profile of:

David Bernard Smith

City:

San Mateo, California

Country:

United States

Published Applications:

Last publication date:

2025-12-18

Top Assignees for applications by David Bernard Smith

The entities that hold a legal rights for patent applications filed by inventor Smith David Bernard:

ALIOS BIOPHARMA, INC. 28 South San Francisco, CA United States
Janssen BioPharma, Inc. 12 South San Francisco, CA United States
Roche Palo Alto LLC 10 Palo Alto, CA United States
Syntex U.S.A. LLC 5 Palo Alto, CA United States
ALIGOS THERAPEUTICS, INC. 5 South San Francisco, CA United States
MEDIVIR AB 3 Huddinge, Sweden
METABASIS THERAPEUTICS, INC. 2 La Jolla, CA United States
Janssen Pharmaceutica NV 2 Beerse, Belgium
Roche Palo Alto 2 Palo Alto, CA United States
Janssen Pharmaceutica NV 1 Breese, Belgium
ROCHE PALO ALTO LLC 1 South San Francisco, CA United States
F. Hoffmann-La Roche AG 1 Basel, Switzerland
Alios Biopharma Inc. 1 San Francisco, CA United States
JANSSEN PHARMACEUTICALS, INC. 1 Titusville, NJ United States
Vertex Pharmaceuticals, Inc. 1 Cambridge, MA United States

Recent patent applications by Smith David Bernard

David Bernard Smith from San Mateo, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-12-18

US20250382618A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR INHIBITING VIRUS

#2 | 2024-05-09

US20240150351A1

Chemistry; metallurgy

BICYCLIC COMPOUNDS

#3 | 2023-12-07

US20230390242A1

Human necessities

PYRROLE COMPOUNDS

#4 | 2023-06-01

US20230167151A1

Chemistry; metallurgy

Substituted nucleosides, nucleotides and analogs thereof

#5 | 2022-05-26

US20220160748A1

Human necessities

CONJUGATES OF S-ANTIGEN TRANSPORT INHIBITING OLIGONUCLEOTIDE POLYMERS HAVING ENHANCED LIVER TARGETING

#6 | 2022-04-28

US20220125825A1

Human necessities

S-ANTIGEN TRANSPORT INHIBITING OLIGONUCLEOTIDE POLYMERS AND METHODS

#7 | 2022-03-10

US20220071957A1

Human necessities

Pyrrole compounds

#8 | 2021-06-24

US20210189392A1

Chemistry; metallurgy

S-ANTIGEN TRANSPORT INHIBITING OLIGONUCLEOTIDE POLYMERS AND METHODS

#9 | 2021-06-24

US20210186969A1

Human necessities

AZA-PYRIDONE COMPOUNDS AND USES THEREOF

#10 | 2021-06-17

US20210179656A1

Chemistry; metallurgy

SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF

#11 | 2021-05-13

US20210139523A1

Chemistry; metallurgy

Substituted nucleosides, nucleotides and analogs thereof

#12 | 2021-04-15

US20210106604A1

Human necessities

Substituted nucleosides, nucleotides and analogs thereof

#13 | 2020-12-31

US20200405743A1

Human necessities

S-antigen transport inhibiting oligonucleotide polymers and methods

#14 | 2020-11-05

US20200345749A1

Human necessities

Bicyclic sulfonamides

#15 | 2020-10-15

US20200323821A1

Human necessities

Pyrrole compounds

#16 | 2020-05-14

US20200147124A1

Human necessities

S-ANTIGEN TRANSPORT INHIBITING OLIGONUCLEOTIDE POLYMERS AND METHODS

#17 | 2020-03-12

US20200079813A1

Chemistry; metallurgy

Substituted nucleosides, nucleotides and analogs thereof

#18 | 2020-01-30

US20200030328A1

Human necessities

Aza-pyridone compounds and uses thereof

#19 | 2020-01-23

US20200024297A1

Chemistry; metallurgy

Substituted nucleosides, nucleotides and analogs thereof

#20 | 2019-12-19

US20190381081A1

Human necessities

SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF

#21 | 2019-10-17

US20190314373A1

Human necessities

AZA-pyridone compounds and uses thereof

#22 | 2019-03-21

US20190085011A1

Chemistry; metallurgy

Substituted nucleosides, nucleotides and analogs thereof

#23 | 2019-02-21

US20190054108A1

Human necessities

Substituted nucleosides, nucleotides and analogs thereof

#24 | 2019-01-31

US20190031703A1

Chemistry; metallurgy

Substituted nucleosides, nucleotides and analogs thereof

#25 | 2018-06-07

US20180155384A1

Chemistry; metallurgy

SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF

#26 | 2018-02-15

US20180044369A1

Chemistry; metallurgy

Substituted nucleosides, nucleotides and analogs thereof

#27 | 2017-05-25

US20170143751A1

Human necessities

Substituted nucleosides, nucleotides and analogs thereof

#28 | 2017-05-25

US20170143749A1

Human necessities

Substituted nucleosides, nucleotides and analogs thereof

#29 | 2017-02-09

US20170037077A1

Chemistry; metallurgy

Substituted nucleosides, nucleotides and analogs thereof

#30 | 2017-02-09

US20170037075A1

Chemistry; metallurgy

Substituted nucleosides, nucleotides and analogs thereof

#31 | 2017-01-05

US20170002037A1

Chemistry; metallurgy

CYCLIC NUCLEOTIDE ANALOGS

#32 | 2016-11-17

US20160331770A1

Human necessities

Substituted nucleosides, nucleotides and analogs thereof

#33 | 2016-09-15

US20160264610A1

Chemistry; metallurgy

AZIDO NUCLEOSIDES AND NUCLEOTIDE ANALOGS

#34 | 2016-09-15

US20160264581A1

Chemistry; metallurgy

Aza-pyridone compounds and uses thereof

#35 | 2016-08-11

US20160228438A1

Human necessities

Aza-pyridone compounds and uses thereof

#36 | 2016-06-23

US20160176911A1

Chemistry; metallurgy

Substituted nucleosides, nucleotides and analogs thereof

#37 | 2016-06-23

US20160176910A1

Chemistry; metallurgy

Substituted nucleosides, nucleotides and analogs thereof

#38 | 2016-02-18

US20160045528A1

Human necessities

COMBINATION THERAPY FOR TREATING A PARAMYXOVIRUS

#39 | 2016-02-11

US20160039861A1

Chemistry; metallurgy

Substituted nucleosides, nucleotides and analogs thereof

#40 | 2016-02-11

US20160039858A1

Chemistry; metallurgy

SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF

#41 | 2016-01-28

US20160024136A1

Chemistry; metallurgy

SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF

#42 | 2016-01-21

US20160016987A1

Chemistry; metallurgy

SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF

#43 | 2015-12-24

US20150366888A1

Human necessities

Substituted nucleosides, nucleotides and analogs thereof

#44 | 2015-12-24

US20150366887A1

Human necessities

Substituted nucleosides, nucleotides and analogs thereof

#45 | 2015-11-05

US20150315228A1

Chemistry; metallurgy

Substituted nucleosides, nucleotides and analogs thereof

#46 | 2015-07-02

US20150183819A1

Chemistry; metallurgy

Azido nucleosides and nucleotide analogs

#47 | 2015-04-16

US20150105341A1

Chemistry; metallurgy

Substituted nucleosides, nucleotides and analogs thereof

#48 | 2015-03-12

US20150072982A1

Chemistry; metallurgy

AZA-pyridone compounds and uses thereof

#49 | 2015-02-19

US20150051167A1

Chemistry; metallurgy

Substituted nucleosides, nucleotides and analogs thereof

#50 | 2015-02-05

US20150038451A1

Chemistry; metallurgy

Substituted nucleotide analogs

#51 | 2014-10-09

US20140303108A1

Chemistry; metallurgy

Cyclic nucleotide analogs

#52 | 2014-06-26

US20140179910A1

Chemistry; metallurgy

Substituted nucleosides, nucleotides and analogs thereof

#53 | 2014-06-26

US20140179627A1

Chemistry; metallurgy

Substituted nucleosides, nucleotides and analogs thereof

#54 | 2013-09-26

US20130252920A1

Human necessities

Pharmaceutical combinations comprising a thionucleotide analog

#55 | 2013-06-27

US20130165400A1

Chemistry; metallurgy

Substituted nucleosides, nucleotides and analogs thereof

#56 | 2012-06-28

US20120165286A1

Chemistry; metallurgy

Cyclic nucleotide analogs

#57 | 2012-03-22

US20120071434A1

Chemistry; metallurgy

Substituted nucleotide analogs

#58 | 2012-03-22

US20120070415A1

Chemistry; metallurgy

Azido nucleosides and nucleotide analogs

#59 | 2012-03-22

US20120070411A1

Chemistry; metallurgy

SUBSTITUTED NUCLEOTIDE ANALOGS

#60 | 2012-02-16

US20120039845A1

Chemistry; metallurgy

NUCLEOSIDE PRODRUGS AND USES THEREOF

#61 | 2011-07-14

US20110172410A1

Chemistry; metallurgy

Antiviral nucleosides

#62 | 2011-06-23

US20110150829A1

Chemistry; metallurgy

Antiviral nucleosides

#63 | 2011-03-24

US20110070190A1

Chemistry; metallurgy

HETEROCYCLIC ANTIVIRAL COMPOUNDS

#64 | 2011-01-20

US20110015148A1

Chemistry; metallurgy

Antiviral nucleosides

#65 | 2010-10-21

US20100267666A1

Chemistry; metallurgy

Pyrrolopyrazine kinase inhibitors

#66 | 2009-08-27

US20090215785A1

Chemistry; metallurgy

Pyrrolopyrazine kinase inhibitors

#67 | 2009-08-27

US20090215750A1

Chemistry; metallurgy

Pyrrolopyrazine kinase inhibitors

#68 | 2009-08-20

US20090209481A1

Chemistry; metallurgy

Nucleoside prodrugs and uses thereof

#69 | 2009-04-09

US20090093525A1

Chemistry; metallurgy

Cyclopropyl aryl amide derivatives and uses thereof

#70 | 2008-06-26

US20080152621A1

Chemistry; metallurgy

Antiviral nucleosides

#71 | 2007-02-22

US20070042988A1

Chemistry; metallurgy

Antiviral phosphoramidates

#72 | 2006-09-12

US10608657

Synthesis of purine derivatives

#73 | 2006-08-03

US20060173075A1

Chemistry; metallurgy

P-(sulfonyl) aryl and heteroarylamines-as anti-inflammatory agents

#74 | 2006-07-04

US9844061

P-(sulfonyl) aryl and heteroarylamines as anti-inflammatory agents

#75 | 2006-05-23

US9925883

Quinoline derivatives as anti-inflammatory agents

#76 | 2006-04-20

US20060084677A1

Chemistry; metallurgy

Quinoline derivatives as anti-inflammatory agents

#77 | 2006-02-23

US20060040890A1

Chemistry; metallurgy

Anti-viral nucleosides

#78 | 2006-01-10

US10719204

Cyclic amine derivatives-CCR-3 receptor antagonists

#79 | 2005-12-20

US10307130

Piperidine CCR-3 receptor antagonists

#80 | 2005-06-14

US10307159

Piperazine CCR-3 receptor antagonists

#81 | 2005-05-31

US10197353

8-aza-11-deoxy prostaglandin analogues

#82 | 2005-02-01

US10197279

2-pyrrolidone derivatives as prostanoid agonists

#83 | 2005-01-25

US10717260

Antiviral nucleoside derivatives

InventorID:

313478 ⎘